Clinical observations and reliability of ECANDOLTM in toxoplasmosis therapy in the african medicine hospitals of the alango foundation in cameroon

TRACK 4 : Global Health / One Health
CBS21_ORA_1223
Clinical observations and reliability of ECANDOLTM in toxoplasmosis therapy in the african medicine hospitals of the alango foundation in cameroon
Francoise xavier Mekambou;
Pepin NKENG-EFOUET-ALANGO*;
Sylviane Poualeu; Bibiane Aimée Wandji;

  1. 3
  2. 1
  3. 13
* Email : pnfalango@yahoo.fr

Toxoplasmosis is a disease that results from infection with the Toxoplasma gondii parasite, one of the world’s most common parasites. Infection usually occurs by eating undercooked contaminated meat, exposure from infected animals feces, or mother-to-child transmission during pregnancy. The main objective of this research is to demonstrate the reliability of the clinical observations as well as the evaluation of the phytomedicines used for the treatment of toxoplasmosis, in relation to other diseases (diseases diagnosed during the first consultation at the same time as the toxoplasmosis). One hundred and forty-one (141) patients of both sexes and of different age groups were sampled for this study from July 2018 to February 2019. The patients were selected according to their regular presence at the monthly appointments. They were admitted for consultation and were followed after the first consultation until recovery. The treatments administered were phytomedicines manufactured and packaged at the Alango Foundation. During the internship, the appropriate diagnostic methods were used and different symptoms of toxoplasmosis were also followed.The results show that among the patients with toxoplamosis, 64.5% were females and 35.5% were males. The distribution of patients by age group showed that patients whose age is between [30-39] years are the most affected with a percentage of 22%. It is clear from this work that as consultations progress, the number of patients decreases. This decrease in the number of patients was correlated with their recovery, thus testifying to the effectiveness of the treatments administered. Thus, 113 patients recovered from toxoplasmosis with a percentage of 80.14%. The present study shows that the management method of toxoplasmosis patients in the Alango Foundation is reliable, thus validating the proven effectiveness of African medicine against toxoplasmosis.

Key words: Toxoplasmosis, Phytomedicines, Healing, Alango Foundation, Clinical observations.